Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
BMS
>>
Phase 1
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
marizomib
(NPI-0052) / Triphase Accelerator Corporation, BMS
urelumab
(BMS-663513) / BMS, Ono Pharma
Angiocept
(pegdinetanib) / BMS
BMS-833923
/ BMS
BMS-936559
/ BMS
MDX-1203
/ BMS
MDX-1342
/ BMS
Onureg
(azacitidine oral) / BMS